Crystalline Management’s SBC Medical Group Warrants SBCWW Stock Holding History

Crystalline Management’s Portfolio SBCWW Stock Details SBCWW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$12K	Hold	80,000	–	–	0.01%	59
2024 Q2	$5.68K	Hold	80,000	–	–	0.01%	68
2024 Q1	$2.8K	Hold	80,000	–	–	﹤0.01%	72
2023 Q4	$2.26K	Hold	80,000	–	–	﹤0.01%	73
2023 Q3	$4.79K	Hold	80,000	–	–	﹤0.01%	92
2023 Q2	$4.76K	Hold	80,000	–	–	﹤0.01%	98
2023 Q1	$2.74K	Buy	+80,000	New	+$5.18K	﹤0.01%	94

Other funds holding SBCWW

Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return

ASM

ATW SPAC Management New York $79.2M AUM 10.67% 1-Year Est. Return

Context Capital Management Lajolla, California $4.89B AUM 1.86% 1-Year Est. Return

Taconic Capital Advisors New York $212M AUM 100.15% 1-Year Est. Return

Schechter Investment Advisors Birmingham, Michigan $1.21B AUM 8.73% 1-Year Est. Return

Meteora Capital Boca Raton, Florida $1.21B AUM 13.69% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

Weiss Asset Management Boston, Massachusetts $9.5B AUM 55.06% 1-Year Est. Return

Shaolin Capital Management Miami, Florida $2.42B AUM 0.61% 1-Year Est. Return

Crystalline Management's SBCWW Position: Q3 2024 in Review

Crystalline Management held its SBC Medical Group Warrants (SBCWW) position steady in Q3 2024 at 80,000 shares worth $12K. The position accounts for 0.01% of the portfolio, ranked #59.

Crystalline Management first reported a position in SBCWW in Q1 2023 and has held it in 7 quarters since. 27 funds tracked by Wall St. Rank hold SBCWW as of Q3 2024.

Crystalline Management held 80,000 shares of SBC Medical Group Warrants worth $12K as of Q3 2024.
Crystalline Management left its SBC Medical Group Warrants share count unchanged in Q3 2024.
SBC Medical Group Warrants made up 0.01% of Crystalline Management's portfolio in Q3 2024, its #59 holding.
Crystalline Management first reported a position in SBC Medical Group Warrants in Q1 2023 and has held it in 7 quarters since.
27 funds tracked by Wall St. Rank held SBC Medical Group Warrants as of Q3 2024.

Based on Crystalline Management's 13F filing for Q3 2024, filed 8 Nov 2024.